Document Type Entity Central Index Key Entity File Number Entity Registrant Name Pre-launch inventories Prelaunch Inventories Current Represents the amount of pre-launch inventories. Trade payables Accounts Payable, Trade, Current Accrued expenses and other current liabilities Accrued Liabilities and Other Liabilities Additional paid-in capital Additional Paid in Capital, Common Stock Property and equipment, net Property, Plant and Equipment, Net Long-term deposits Other Assets, Noncurrent Total assets Assets Current maturities of long-term debt Long-Term Debt, Current Maturities Total current liabilities Liabilities, Current Other liabilities Other Liabilities, Noncurrent COMMITMENTS AND CONTINGENT LIABILITIES Commitments and Contingencies Long-term operating lease liabilities Operating Lease, Liability, Noncurrent Ordinary shares, par value (in Dollars per share) Common Stock, No Par Value Ordinary shares, shares issued (in Shares) Ordinary shares, Issued Common Stock, Shares, Issued Ordinary shares, no par value - Authorized: 107,800,000 shares at June 30, 2026 and December 31, 2025; Issued and outstanding: 20,311,766 and 18,204,002 shares at June 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Accumulated deficit Retained Earnings (Accumulated Deficit) Loss before income tax Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Basic loss per Ordinary share Earnings Per Share, Basic Total long-term assets Assets, Noncurrent CURRENT LIABILITIES: Liabilities, Current [Abstract] Current maturities of operating lease liabilities Operating Lease, Liability, Current Total long-term liabilities Liabilities, Noncurrent SHAREHOLDERS’ EQUITY: Equity, Attributable to Parent [Abstract] LONG-TERM LIABILITIES: Liabilities, Noncurrent [Abstract] LONG-TERM ASSETS: Assets, Noncurrent [Abstract] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Deferred revenues Contract with Customer, Liability, Noncurrent Total liabilities and shareholders’ equity Liabilities and Equity Statement of Financial Position [Abstract] Ordinary shares, shares authorized (in Shares) Ordinary shares, Authorized Common Stock, Shares Authorized Ordinary shares, shares outstanding (in Shares) Balance (in Shares) Balance (in Shares) Ordinary shares, outstanding Common Stock, Shares, Outstanding Total shareholders’ equity Balance Balance Equity, Attributable to Parent Diluted loss per Ordinary share Earnings Per Share, Diluted General and administrative General and Administrative Expense Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt CURRENT ASSETS: Assets, Current [Abstract] Restricted deposits Restricted Cash, Current Total current assets Assets, Current Cash and cash equivalents Cash and Cash Equivalent Short-term deposits Deposits Assets, Current Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Non-cash financial expenses, net Noncash Contribution Expense Share-based compensation expenses Share-Based Payment Arrangement, Noncash Expense Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Operating lease liabilities Increase (Decrease) in Operating Lease Liability Accrued expenses and other liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Operating expenses: Operating Expenses [Abstract] Marketing and business development Marketing and Advertising Expense Net loss Net loss Net Income (Loss) Weighted average number of Ordinary shares used in computing diluted loss per share Weighted Average Number of Shares Outstanding, Diluted Statement of Stockholders' Equity [Abstract] Equity Components [Axis] Additional paid-in capital Additional Paid-in Capital [Member] Equity Component [Domain] Share-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Cash, cash equivalents and restricted deposits at the beginning of the period Cash, cash equivalents and restricted deposits at the end of the period Cash, cash equivalents and restricted deposits at the end of the period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Operating loss Operating Income (Loss) Financial expenses (income), net Nonoperating Income (Expense) Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Restricted deposits Restricted Cash and Cash Equivalent, Current Depreciation of property and equipment Depreciation Line of Credit Agreement [Abstract] COMMITMENTS AND CONTINGENT LIABILITIES Commitments and Contingencies Disclosure [Text Block] SHAREHOLDERS’ EQUITY Equity [Text Block] BASIC AND DILUTED LOSS PER SHARE Earnings Per Share [Text Block] Schedule of Share-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Recently issued accounting pronouncements not yet adopted Accounting Standards Update and Change in Accounting Principle [Text Block] Basic and diluted loss per share Earnings Per Share, Policy [Policy Text Block] Shareholders’ Equity [Abstract] General [Abstract] SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Shareholders’ Equity - Schedule of Options to Employees Under the Company’s Option Plan (Details) [Table] Employees and Non-Employees [Member] Employees And Non Employees Member Number of options, Outstanding beginning balance Number of options, Outstanding ending balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Aggregate intrinsic value, Outstanding beginning balance Aggregate intrinsic value, Outstanding ending balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Related and Nonrelated Parties [Domain] Subsequent Event Type [Domain] Option [Member] Ordinary share options [Member] Equity Option [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Private Placement [Member] Private Placement [Member] Statistical Measurement [Axis] Ordinary Shares [Member] Number of ordinary shares Common Stock [Member] Class of Warrant or Right [Axis] Abeyance [Member] Abeyance Member Fair value warrant price per share (in Dollars per share) Fair Value Of Warrant Price Per Share Represent the amount of fair value warrant price per share. Proceeds amount (in Dollars) Proceeds To Issuance Cost Net Amount Represent the amount of proceeds to issuance cost net. Warrants expired shares Class of Warrant or Right, Unissued Weighted average grant date fair value of options granted (in Dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Commitments and Contingent Liabilities (Details) [Table] Unrecognized compensation costs (in Dollars) Unrecognized Compensation Costs Amount of unrecognized compensation costs. Subsequent Events [Abstract] Subsequent Event Type [Axis] Title and Position [Domain] August 2024 [Member] August2024 Member Class of Warrant or Right [Domain] Award Date [Axis] Net of issuance cost (in Dollars) Payments of Stock Issuance Costs Total amount of warrants exercised (in Dollars) Proceeds from warrant exercises (in Dollars) Proceeds from Warrant Exercises Schedule Of Share Based Compensation Expense Abstract Award Date [Domain] July 2022 [Member] July2022 Member Warrants outstanding as of June 30, 2026 (in Shares) Warrants outstanding Class of Warrant or Right, Outstanding Warrants exercisable as of June 30, 2026 Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number Number of non-option equity instruments exercisable. Company incorporation date Entity Incorporation, Date of Incorporation Cash flows from operating activities Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Class of Warrant or Right [Table] Warrants to purchase Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants expire Warrants and Rights Outstanding, Term Net of issuance cost (in Dollars) Proceeds from Debt, Net of Issuance Costs Subsequent Events [Line Items] Subsequent Event [Line Items] Issuance of ordinary shares Number of share issued Stock Issued During Period, Shares, New Issues Schedule of Diluted Loss Per Share Attributable to Shareholders Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Additional payment Amount of Upfront Payment Amount of upfront payment. Payments receivable Milestone Payments Receivable Amount of milestone payments receivable. April 2022 [Member] April 2022 One [Member] Award Type [Axis] Award Type [Domain] New Drug Application [Member] Warrants were canceled Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture, Total Statement of Income Location [Axis] Statement of Income Location [Domain] Research and Development Expenses [Member] Research and development [Member] Weighted average exercise price, Outstanding ending balance Weighted average exercise price, Outstanding beginning balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Ending Balance Weighted average remaining contractual life (years), Outstanding balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Marketing and business development [Member] General and administrative [Member] Weighted average remaining contractual life (years), Exercisable options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted average exercise price, Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Aggregate intrinsic value, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Weighted average exercise price, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Weighted average remaining contractual life (years), Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Weighted average exercise price, Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average exercise price, Exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Schedule of Share-Based Compensation Expense [Line Items] January 2024 Warrants [Member] January2024 Warrants Member August 2024 Warrants [Member] August2024 Warrants Member New Warrants [Member] New Warrants Member Shareholders’ Equity [Line Items] Aggregate offering price (in Dollars) Deferred Offering Costs June 2025 [Member] June2025 Member Schedule of Warrants Exercisable Into Ordinary Shares [Line Items] Average exercise price per share Exercise price per share (in Dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Exercisable through Share Based Compensation Arrangement Exercisable Date Exercisable. Percentage of reduction rate of surgical site Percentage Of Reduction Rate Of Surgical Site Percentage of reduction rate of surgical site. Schedule Of Warrants Exercisable Into Ordinary Shares Abstract Commitments and Contingent Liabilities [Line Items] Percentage of royalties rate of sales Percentage Of Royalties Rate Of Sales Represent the percentage of royalties rate of sales. Payment of royalties Prepaid Royalties Description of stock option vesting period Stock Option Vesting Period Description Description of stock option vesting period. Commitments and Contingent Liabilities [Abstract] Recognized weighted average period Recognized Weighted Average Period Recognized weighted average period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Subsequent Events (Details) [Table] Subsequent Event [Member] Subsequent Event [Member] Inducement Letter [Member] Inducement Letter Member Sale of Stock [Domain] IPO [Member] IPO [Member] Title and Position [Axis] Israel Innovation Authority of the Ministry of Economy [Member] Israel Innovation Authority Of The Ministry Of Economy Member New warrants of shares exercised Warrants Exercise Warrants of shares exercised. Amendment Flag Cover [Abstract] Current Fiscal Year End Date Document Fiscal Period Focus Document Fiscal Year Focus Document Information [Line Items] Document Information [Table] Document Period End Date Proceeds from issuance of Ordinary shares, warrants and pre-funded warrants, net Proceeds from Issuance of Warrants Proceeds from bank deposits Proceeds from Other Deposits Net cash provided by (used in) investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Exercise of options Stock Issued During Period, Value, Stock Options Exercised Statement of Cash Flows [Abstract] Exchange rate differences gain on cash balances Increase Decrease in Exchange Rate Differences Gain on Cash Balances The amount of exchange rate differences gain on cash balances. Exchange rate differences on cash and cash equivalent balances Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Increase in cash, cash equivalents and restricted deposits Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Pre-launch inventories Increase Decreasein Prelaunch Inventories The increase (decrease) during the reporting period in the aggregate value of pre-launch inventories. Operating lease right-of-use-assets Increase (Decrease) in Other Operating Assets Trade payables Increase (Decrease) in Accounts Payable, Trade Investment in bank deposits Payments to Acquire Short-Term Investments Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Changes in assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Payments due to long-term debt Repayments of Long-Term Debt Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Exercise of options (in Shares) Number of options, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Income Statement [Abstract] Research and development Research and Development Expense Income tax expenses Income Tax Expense (Benefit) Weighted average number of Ordinary shares used in computing basic loss per share Weighted Average Number of Shares Outstanding, Basic Statement [Table] Accumulated deficit Retained Earnings [Member] Statement [Line Items] Issuance of Ordinary shares, abeyance shares and warrants, net Stock Issued During Period Value Issuanceof Ordinary Shares Abeyance Sharesand Warrants Net The amount of issuance of ordinary shares, abeyance shares and warrants, net. Exercise of pre-funded warrants Stock Issued During Period Value Exercise Of Prefunded Warrants Stock issued during period value exercise of prefunded warrants. Issuance of Ordinary shares, abeyance shares and warrants, net (in Shares) Stock Issued During Period Shares Issuanceof Ordinary Shares Abeyance Sharesand Warrants Net Number of issuance of ordinary shares, abeyance shares and warrants, net. Exercise of pre-funded warrants (in Shares) Stock Issue During Period Shares Exercise Of Prefunded Warrants Number of shares exercise of pre-funded warrants. Schedule of Ordinary Share Capital Schedule Of Ordinary Share Capital Table Text Block Tabular disclosure of ordinary share capital. Schedule of Options to Employees and Non-Employees Under the Company’s Option Plan Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of Warrants Exercisable into Ordinary Shares Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Basis of presentation and summary of significant accounting policies Basis of Accounting, Policy [Policy Text Block] GENERAL Basis of Accounting [Text Block] Significant Accounting Policies [Abstract] LINE OF CREDIT AGREEMENT Debt Disclosure [Text Block] Basic and Diluted Loss Per Share [Abstract] SUBSEQUENT EVENTS Subsequent Events [Text Block] Shareholders’ Equity (Details) [Table] Maximum [Member] Maximum [Member] Class of Stock [Axis] Pre Funded Warrants [Member] Pre Funded Warrants Member Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Number of options, Exercisable options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Aggregate intrinsic value, Exercisable options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Schedule of Diluted Net Loss Per Share Attributable to Shareholders Abstract Antidilutive Securities [Axis] Number of options, Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Aggregate intrinsic value, Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Number of options, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Number of options, Expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Number of options, Granted Options granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Total share-based compensation expense Share-Based Payment Arrangement, Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] April 2022 [Member] April2022 Member Warrant [Member] Warrants [Member] Warrant [Member] December 2024 Warrants [Member] December2024 Warrants Member New Warrants Shares [Member] New Warrants Shares Member Number of shares issued Sale of Stock, Number of Shares Issued in Transaction Officers [Member] Officers Member Entity [Domain] Schedule of Ordinary Share Capital [Abstract] Schedule Of Options To Employees Under The Company SOption Plan Abstract Related and Nonrelated Parties [Axis] Schedule of Options to Employees Under the Company’s Option Plan [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Participation payments Proceeds From Participation Payments Participation payments received. Percentage of grant received Percentage Of Grant Received Percentage of grant received. Accrued royalty Accrued Royalties, Current Equity issuance cost (in Dollars) Proceeds from Issuance or Sale of Equity Statistical Measurement [Domain] Sale of Stock [Axis] Minimum [Member] Minimum [Member] Class of Stock [Domain] Weighted average exercise price, Exercisable options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities, Name [Domain] Antidilutive shares Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Schedule of Diluted Loss Per Share Attributable to Shareholders [Line Items] Schedule of Diluted Net Loss Per Share Attributable to Ordinary Shareholders [Line Items] Price per share (in Dollars per share) Sale of Stock, Price Per Share Offering proceeds (in Dollars) Proceeds from Issuance of Private Placement Scenario [Axis] Scenario [Domain] Forecast [Member] Weighted average exercise price, Expired Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Legal Entity [Axis] Definitive Securities Purchase Agreement [Member] Definitive Securities Purchase Agreement Member Amount of net issuance cost (in Dollars) Proceeds from Issuance of Common Stock Investors purchased shares Stock Issued During Period, Shares, Other Warrant exercise price (in Dollars per share) Warrant, Exercise Price, Increase Additional gross proceeds (in Dollars) Proceeds from Issuance Initial Public Offering Number of voting rights Common Stock, Voting Rights